Churchill Capital Corp. filed for a $400 million IPO very late Friday evening, with a focus on the technology and software sectors. Churchill is being led by Jerre Stead, as CEO and Director, and Michael Klein, as Chairman. This SPAC team has quite a few impressive names, from top to bottom.
In addition to Mr. Stead, who is the former Chairman and CEO of IHS Markit Ltd. (Nasdaq:INFO), and Mr. Klein, who is currently a Director of Credit Suisse and the Founder and Managing Partner of M. Klein and Company, the team includes a former member of President Barack Obama’s Cabinet (Karen Mills) and former Chairman of British Airways (Sir Martin Broughton). You can read the team’s full bios here.
This is another big SPAC from Citigroup on the heels of the $552 million Spartan Energy Acquisition Corp. However, given that Michael Klein is a Director of Credit Suisse, it’s surprising Credit Suisse is not an underwriter. Maybe they will be added at a later date or maybe there’s a conflict of interest I’m missing, but the absence was noted.
As far as structure, Churchill follows the typical Tier-1 structures found on the NYSE, except, instead of one-third of one warrant, the unit will be offering one-half of one warrant. The sponsor, which is an affiliate of M. Klein and Company, will be purchasing 12,500,000 warrants at $1.00 for total at-risk capital of $12.5 million (before over-allotment). Full summary of terms below.
Churchill Capital Corp. Summary of Terms:
- Focus: Technology / Software
- Size: $400 million
- 100% held in trust ($10.00 per share)
- $10.00 unit comprised of one share of Class A Common Stock + 1/2 of one Warrant
- Warrant call for redemption threshold: equals or exceeds $18.00 (cash or cashless exercise)
- 24 months to complete an acquisition
- Limitation on Redemption Rights: 15%
- At-risk Capital: $12.5 million (12,500,000 warrants at $1.00)
- Underwriter fees: 2.0% + 3.5% deferred.
Citigroup is sole book-runner.
Paul, Weiss, Rifkind, Wharton & Garrison LLP and Winston & Strawn LLP are Issuer’s Counsel and Underwriter’s Counsel, respectively.
Terms Tracker for the Week Ending November 24, 2023 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. This being the Thanksgiving holiday week, we are thankful for a lot of things, but mostly that 2023 is almost over. It’s been a rough...
At the SPAC of Dawn Though perhaps stuffed to the brim, SPAC activity continues this Thanksgiving Friday with votes by Clean Earth and Zalatoris to extend a deadline and amend trust contributions, respectively. At least seven de-SPACs are also reporting earnings today and will do so going into a futures market that is mostly green...
IB Acquisition Corp. submitted its S-1 filing Friday afternoon for a $100 million IPO, coming right on the heels of Bayview Acquisition Corp, which also filed its S-1 that day. IB is also similar to Bayview in that its units do not feature a warrant but include 1 right for 1/10. However, its trust is slightly...
Integrated Wellness (NYSE:WEL) announced in an 8-K filing that it agreed to transfer control of its sponsor to Sriram Associates, which will now take on the SPAC’s financial obligations and may appoint a new team. Sriram is acquiring 2,012,500 promote shares (70%) and 4,795,000 private placement warrants (70%) for the nominal purchase price of $1....
At the SPAC of Dawn So far, seven SPACs have announced their liquidations this week and although some others may choose to use the holiday to quietly disband, this tends to be a positive week for equities in general. Going back to 1961, the S&P 500 has ended the Thanksgiving week with gains three-quarters of...